Kim Ju Hee, Ku Bonsu, Lee Kyung S, Kim Seung Jun
Functional Genomics Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 305-806, Korea.
Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 20892.
Proteins. 2015 Jul;83(7):1201-8. doi: 10.1002/prot.24804. Epub 2015 Apr 28.
Polo-like kinases (Plks) are the key regulators of cell cycle progression, the members of which share a kinase domain and a polo-box domain (PBD) that serves as a protein-binding module. While Plk1 is a promising target for antitumor therapy, Plk2 is regarded as a tumor suppressor even though the two Plks commonly recognize the S-pS/T-P motif through their PBD. Herein, we report the crystal structure of the PBD of Plk2 at 2.7 Å. Despite the overall structural similarity with that of Plk1 reflecting their high sequence homology, the crystal structure also contains its own features including the highly ordered loop connecting two subdomains and the absence of 310 -helices in the N-terminal region unlike the PBD of Plk1. Based on the three-dimensional structure, we furthermore could model its interaction with two types of phosphopeptides, one of which was previously screened as the optimal peptide for the PBD of Plk2.
Polo样激酶(Plks)是细胞周期进程的关键调节因子,其成员共享一个激酶结构域和一个作为蛋白质结合模块的polo盒结构域(PBD)。虽然Plk1是抗肿瘤治疗的一个有前景的靶点,但Plk2被视为一种肿瘤抑制因子,尽管这两种Plk通常通过其PBD识别S-pS/T-P基序。在此,我们报道了Plk2的PBD在2.7 Å分辨率下的晶体结构。尽管与Plk1的整体结构相似反映了它们的高序列同源性,但该晶体结构也有其自身特点,包括连接两个亚结构域的高度有序环,以及与Plk1的PBD不同,在N端区域没有310螺旋。基于三维结构,我们还能够模拟其与两种磷酸肽的相互作用,其中一种磷酸肽先前被筛选为Plk2的PBD的最佳肽。